Partial evidence of an association between epidermal growth factor A61G polymorphism and age at onset in male schizophrenia

Neuroscience Research

Volumn 56, Issue 4, 2006, Pages 356-362

  Lee, Kyu Young ^a   Ahn, Yong Min ^a,b   Joo, Eun Jeong ^c   Joo, Yeon Ho ^d   Chang, Jae Seung ^a   Yoo, Han Young ^a   Kim, Yong Sik ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Eulji General Hospital   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

Age at onset; Association; EGF; Gender; Schizophrenia

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; SAMPLE; SCHIZOPHRENIA; SEX DIFFERENTIATION;

ADOLESCENT; ADULT; AGE OF ONSET; ALLELES; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 33751021702     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.08.004     Document Type: Article

References (39)

1. Abdolmaleky H.M., Faraone S.V., Glatt S.J., and Tsuang M.T. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr. Res. 67 (2004) 53-62
2. Anttila S., Illi A., Kampman O., Mattila K.M., Lehtimaki T., and Leinonen E. Association of EGF polymorphism with schizophrenia in Finnish men. Neuroreport 15 (2004) 1215-1218
3. Barrie A., Chieregatti E., Miloso M., Benfenati F., and Valtorta F. Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes. Mol. Pharmacol. 49 (1996) 399-403
4. Beiser M., Erickson D., Fleming J.A., and Iacono W.G. Establishing the onset of psychotic illness. Am. J. Psychiatry 150 (1993) 1349-1354
5. Belcher S.M., Le H.H., Spurling L., and Wong J.K. Rapid estrogenic regulation of extracellular signal-regulated kinase 1/2 signaling in cerebellar granule cells involves a G protein and protein kinase A dependent mechanism and intracellular activation of protein phosphatase 2A. Endocrinology 146 (2005) 5397-5406
6. Brannvall K., Korhonen L., and Lindholm D. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol. Cell Neurosci. 21 (2002) 512-520
7. Callier S., Morissette M., Grandbois M., Pelaprat D., and Di Paolo T. Neuroprotective properties of 17beta-estradiol, progesterone and raloxifene in MPTP C57Bl/6 mice. Synapse 41 (2001) 131-138
8. Fanous A.H., and Kendler K.S. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol. Psychiatry 10 (2005) 6-13
9. Farkas L.M., and Krieglstein K. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J. Neural Transm. 109 (2002) 267-277
10. Futamura T., Toyooka K., Iritani S., Niizato K., Nakamura R., Tsuchiya K., Someya T., Kakita A., Takahashi H., and Nawa H. Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol. Psychiatry 7 (2002) 673-682
11. Futamura T., Kakita A., Tohmi M., Sotoyama H., Takahashi H., and Nawa H. Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol. Psychiatry 8 (2003) 19-29
12. Hadjiconstantinou M., Fitkin J.G., Dalia A., and Neff N.H. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J. Neurochem. 57 (1991) 479-482
13. Hanninen, K., Katila, H., Anttila, S., Rontu, R., Maaskola, J., Hurme, M., Lehtimaki, T. Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients. J. Psychiatr. Res., in press.
14. Herbison A.E. Estrogen regulation of GABA transmission in rat preoptic area. Brain Res. Bull. 44 (1997) 321-326
15. Iwakura Y., Piao Y.S., Mizuno M., Takei N., Kakita A., Takahashi H., and Nawa H. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. J. Neurochem. 93 (2005) 974-983
16. Jeong S.H., Joo E.J., Ahn Y.M., and Kim Y.S. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 975-983
17. Kajta M., and Beyer C. Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine 21 (2003) 3-9
18. Keshavan M.S., and Hogarty G.E. Brain maturational processes and delayed onset in schizophrenia. Dev. Psychopathol. 11 (1999) 525-543
19. Kester H.M., Sevy S., Yechiam E., Burdick K.E., Cervellione K.L., and Kumra S. Decision-making impairments in adolescents with early-onset schizophrenia. Schizophr. Res. 85 (2006) 113-123
20. Kow L.M., and Pfaff D.W. Estrogen effects on neuronal responsiveness to electrical and neurotransmitter stimulation: an in vitro study on the ventromedial nucleus of the hypothalamus. Brain Res. 347 (1985) 1-10
21. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res. Brain Res. Rev. 31 (2000) 371-384
22. Lee K.Y., Ahn Y.M., Joo E.J., Jeong S.H., Chang J.S., Kim S.C., and Kim Y.S. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci. Lett. 395 (2006) 175-178
23. Lim Y.J., Kim J.W., Song J.Y., Hong M.S., Jin S.Y., Yoon S.H., Park H.J., Choe B.K., Lee J.J., Yim S.V., Hong S.I., Baik H.H., Ha E., and Park Y.H. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci. Lett. 374 (2005) 157-160
24. Morton C.C., Byers M.G., Nakai H., Bell G.I., and Shows T.B. Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet. Cell Genet. 41 (1986) 245-249
25. Paunio T., Ekelund J., Varilo T., Parker A., Hovatta I., Turunen J.A., Rinard K., Foti A., Terwilliger J.D., Juvonen H., Suvisaari J., Arajarvi R., Suokas J., Partonen T., Lonnqvist J., Meyer J., and Peltonen L. Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum. Mol. Genet. 10 (2001) 3037-3048
26. Prevot V., Rio C., Cho G.J., Lomniczi A., Heger S., Neville C.M., Rosenthal N.A., Ojeda S.R., and Corfas G. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J. Neurosci. 23 (2003) 230-239
27. Prevot V., Lomniczi A., Corfas G., and Ojeda S.R. erbB-1 and erbB-4 receptors act in concert to facilitate female sexual development and mature reproductive function. Endocrinology 146 (2005) 1465-1472
28. Rao M.L., and Kolsch H. Effects of estrogen on brain development and neuroprotection: implications for negative symptoms in schizophrenia. Psychoneuroendocrinology 28 Suppl. 2 (2003) 83-96
29. Rapoport J.L., Addington A.M., Frangou S., and Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 10 (2005) 434-449
30. Sawada H., Ibi M., Kihara T., Urushitani M., Akaike A., and Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J. Neurosci. Res. 54 (1998) 707-719
31. Schwarz M.J., Kronig H., Riedel M., Dehning S., Douhet A., Spellmann I., Ackenheil M., Moller H.J., and Muller N. IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 72-76
32. Shahbazi M., Pravica V., Nasreen N., Fakhoury H., Fryer A.A., Strange R.C., Hutchinson P.E., Osborne J.E., Lear J.T., Smith A.G., and Hutchinson I.V. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359 (2002) 397-401
33. Takase K., Ohtsuki T., Migita O., Toru M., Inada T., Yamakawa-Kobayashi K., and Arinami T. Association of ZNF74 gene genotypes with age-at-onset of schizophrenia. Schizophr. Res. 52 (2001) 161-165
34. Tuulio-Henriksson A., Partonen T., Suvisaari J., Haukka J., and Lonnqvist J. AAO and cognitive functioning in schizophrenia. Br. J. Psychiatry 185 (2004) 215-219
35. Watanabe Y., Fukui N., Muratake T., Kaneko N., and Someya T. No association of EGF polymorphism with schizophrenia in a Japanese population. Neuroreport 16 (2005) 403-405
36. Weinberger D.R. The biological basis of schizophrenia: new directions. J. Clin. Psychiatry 58 Suppl. 10 (1997) 22-27
37. Welham J.L., Pemberton M.R., and McGrath J.J. Incorporating lag effects in register-based age-of-onset distributions in schizophrenia. Schizophr. Res. 20 (1996) 125-132
38. White T., Ho B.C., Ward J., O'leary D., and Andreasen N.C. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects. Biol. Psychiatry 60 (2006) 463-471
39. Wong R.W., and Guillaud L. The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev. 15 (2004) 147-156